ERBB2 and breast carcinoma: To overcome such potential limitations, we developed an 18-gene classifier (18-GC) with tumor tissues obtained from Asian breast cancer patients and compared its performance with that of ODx in predicting distant metastasis in early-stage HR+/HER2- patients.